Catalyst Pharmaceuticals Inc (CPRX) Insider Trading
- $5,728,674.40
- $33,898,420.51
- May 15, 2023
- Patrick J Mcenany
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 15, 2023 | CEO | 26,151 | $13.23 | Sell | $345,977.73 | |
April 5, 2023 | Director | 30,000 | $16.83 | Sell | $504,900.00 | |
March 29, 2023 | Insider | 40,000 | $16.70 | Sell | $668,000.00 | |
March 28, 2023 | CFO | 58,216 | $16.54 | Sell | $962,892.64 | |
March 22, 2023 | CFO | 41,784 | $16.50 | Sell | $689,436.00 | |
March 20, 2023 | Insider | 50,000 | $16.07 | Sell | $803,500.00 | |
Dec. 6, 2022 | Insider | 5,918 | $16.85 | Sell | $99,718.30 | |
Nov. 23, 2022 | COO | 20,000 | $17.34 | Sell | $346,800.00 | |
Nov. 23, 2022 | Director | 9,999 | $17.45 | Sell | $174,482.55 | |
Nov. 22, 2022 | CFO | 120,000 | $16.53 | Sell | $1,983,600.00 | |
Nov. 21, 2022 | Director | 70,000 | $15.23 | Sell | $1,066,100.00 | |
Nov. 21, 2022 | CEO | 150,000 | $15.33 | Sell | $2,299,500.00 | |
Nov. 21, 2022 | COO | 80,000 | $15.28 | Sell | $1,222,400.00 | |
Nov. 18, 2022 | CEO | 350,000 | $15.62 | Sell | $5,467,000.00 | |
Nov. 15, 2022 | CFO | 60,000 | $15.77 | Sell | $946,200.00 | |
Nov. 11, 2022 | Director | 20,000 | $16.59 | Sell | $331,800.00 | |
Nov. 11, 2022 | insider | 56,786 | $16.38 | Sell | $930,154.68 | |
Sept. 23, 2022 | CFO | 60,000 | $11.90 | Sell | $714,000.00 | |
Sept. 16, 2022 | CFO | 90,000 | $13.50 | Sell | $1,215,000.00 | |
Sept. 15, 2022 | insider | 18,214 | $14.49 | Sell | $263,920.86 | |
Sept. 14, 2022 | Director | 20,000 | $15.34 | Sell | $306,800.00 | |
Sept. 14, 2022 | CFO | 50,000 | $15.57 | Sell | $778,500.00 | |
Sept. 13, 2022 | CEO | 80,765 | $15.33 | Sell | $1,238,127.45 | |
Sept. 13, 2022 | COO | 107,933 | $16.90 | Sell | $1,824,067.70 | |
Aug. 29, 2022 | CFO | 57,000 | $14.20 | Sell | $809,400.00 | |
Aug. 26, 2022 | CFO | 11,095 | $14.40 | Sell | $159,768.00 | |
Aug. 22, 2022 | Director | 20,000 | $14.16 | Sell | $283,200.00 | |
Aug. 18, 2022 | COO | 150,000 | $13.53 | Sell | $2,029,500.00 | |
Aug. 17, 2022 | CFO | 130,741 | $13.86 | Sell | $1,812,070.26 | |
June 22, 2022 | Insider | 6,152 | $6.61 | Sell | $40,664.72 | |
Dec. 7, 2021 | Insider | 3,612 | $6.99 | Sell | $25,247.88 | |
Aug. 25, 2021 | COO | 80,000 | $5.56 | Sell | $444,800.00 | |
Aug. 25, 2021 | Director | 9,498 | $5.56 | Sell | $52,808.88 | |
Aug. 23, 2021 | CEO | 82,617 | $5.62 | Sell | $464,307.54 | |
Aug. 20, 2021 | CEO | 54,161 | $5.52 | Sell | $298,968.72 | |
Aug. 17, 2021 | CFO | 100,000 | $5.67 | Sell | $567,000.00 | |
Dec. 22, 2020 | Insider | 3,668 | $3.45 | Sell | $12,654.60 | |
Sept. 30, 2020 | Director | 7,000 | $2.99 | Buy | $20,930.00 | |
Sept. 30, 2020 | CEO | 15,000 | $2.97 | Buy | $44,550.00 | |
Dec. 5, 2019 | Insider | 150,000 | $4.82 | Sell | $723,000.00 | |
Nov. 27, 2019 | Insider | 100,000 | $4.66 | Sell | $466,000.00 | |
Nov. 21, 2019 | Insider | 100,000 | $4.50 | Sell | $450,000.00 | |
Oct. 11, 2019 | Director | 10,000 | $4.70 | Buy | $47,000.00 | |
Oct. 3, 2019 | CEO | 10,000 | $4.89 | Buy | $48,900.00 | |
June 11, 2019 | CEO | 25,000 | $3.23 | Buy | $80,750.00 | |
Dec. 27, 2018 | Director | 25,000 | $1.91 | Buy | $47,750.00 | |
Dec. 19, 2018 | Insider | 20,000 | $2.24 | Buy | $44,800.00 | |
Dec. 14, 2018 | Director | 20,000 | $2.50 | Buy | $50,000.00 | |
June 7, 2018 | Director | 4,000 | $3.31 | Buy | $13,240.00 | |
June 1, 2018 | Director | 5,000 | $3.74 | Buy | $18,700.00 |
Insiders are both buying and selling Catalyst Pharmaceuticals Inc stock.
The insider traders at Catalyst Pharmaceuticals Inc are: Patrick J Mcenany, Charles B O'keeffe, Alicia Grande, Donald A Denkhaus, Gary Ingenito, Steve Miller, Philip H Coelho, David D Muth, David S Tierney, Charles O'keeffe, Preethi Sundaram, Patrick Mcenany, M Douglas Winship, Brian Elsbernd, Carmen Jeffrey Del, and Biomarin Pharmaceutical Inc
The most active insider trader at Catalyst Pharmaceuticals Inc is Patrick J Mcenany with 22 trades.
Alicia Grande has sold the most Catalyst Pharmaceuticals Inc stock with a total value of $11,600,759.54.
Biomarin Pharmaceutical Inc has bought the most Catalyst Pharmaceuticals Inc stock with a total value of $7,500,000.00.
The most recent insider trade for Catalyst Pharmaceuticals Inc was on May 15, 2023.
The single biggest insider buy for Catalyst Pharmaceuticals Inc was from Biomarin Pharmaceutical Inc with a total value of $3,750,000.00 on Dec. 8, 2012.
The single biggest insider sell for Catalyst Pharmaceuticals Inc was from Patrick J Mcenany with a total value of $5,467,000.00 on Nov. 18, 2022.